The addition of dexamethasone to antiandrogen therapy for hirsutism prolongs the duration of remission

Fertility and Sterility

Volumn 69, Issue 6, 1998, Pages 1075-1079

  Carmina, Enrico ^a   Lobo, Rogerio A ^a  

^a Coll of Phys/Surgs of Columbia U ^*  (United States)

Author keywords

Antiandrogens; Dexamethasone; Hirsutism; Hyperandrogenism

Indexed keywords

ANTIANDROGEN; DEXAMETHASONE; PRASTERONE SULFATE; SPIRONOLACTONE; TESTOSTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIRSUTISM; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REMISSION; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; ANDROGEN ANTAGONISTS; COHORT STUDIES; DEXAMETHASONE; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HIRSUTISM; HUMANS; HYPERANDROGENISM; REMISSION INDUCTION; SPIRONOLACTONE; TIME FACTORS;

EID: 0032101335     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00061-2     Document Type: Article

References (13)

1. 1. Lobo RA. Hirsutism, alopecia and acne. In: Becker KL, editor. Principles and practice of endocrinology and metabolism. Philadelphia: Lippincott, 1995:924-40.
2. 2. Rittmaster RS. Medical treatment of androgen dependent hirsutism. J Clin Endocrinol Metab 1995;80:2559-63.
3. 3. Carmina E, Lobo RA. GnRH-agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission. Hum Reprod 1997;12:663-6.
4. 4. Carmina E, Stanczyk FZ, Gentzschein E, Lobo RA. Time dependent changes in serum 3α-androstenediol glucuronide correlate with hirsutism scores after ovarian suppression. Gynecol Endocrinol 1995;9:215-20.
5. 5. Axelrod L. Corticosteroid therapy. In: Becker KL, editor. Principles and practice of endocrinology and metabolism. Philadelphia: Lippincott, 1995:695-706.
6. 6. Carmina E, Lobo RA. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism. Obstet Gynecol 1991;18:845-9.
7. 7. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology and management. Am J Obstet Gynecol 1981;140:815-30.
8. 8. Mishell DR, Nakamura RM, Crosignani PG, Stove S, Kharva K, Nagata Y, et al. Serum gonadotropins and steroid patterns during the normal menstrual cycle. Am J Obstet Gynecol 1971;111:60-5.
9. 9. Goebelsmann V, Arce JJ, Thorneycroft IH, Mishell DR. Serum testosterone concentrations in women throughout the menstrual cycle and following hCG administration. Am J Obstet Gynecol 1974;119:445-52.
10. 10. Lobo RA, Kletzky DA, Kaptein EM, Goebelsmann U. Prolactin modulation of dehydroepiandrosterone sulfate secretion. Am J Obstet Gynecol 1980;138:632-6.
11. 11. Carmina E. Pathogenesis and treatment of hirsutism in late-onset congenital adrenal hyperplasia. Reprod Med Rev 1995;4:179-87.
12. 12. Graber AL, Ney RL, Nicholson WE, Island DP, Liddle GW. Natural history of pituitary adrenal recovery following long term suppression with corticosteroids. J Clin Endocrinol 1965;25:11-6.
13. 13. Rittmaster RS, Loriaux DL, Cutler GB Jr. Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women. J Clin Endocrinol Metab 1985;61:462-6.